The market value of the company surpassed the size of Denmark’s entire economy last year and, for a period, Novo Nordisk was ...

Dozens of lawmakers are urging US health regulators to crack down on the booming market for knockoff weight-loss drugs amid mounting concerns over their potential safety risks.

The European Union and the US appear to differ on some fundamental details in their new trade agreement, underscoring the ...

Several anti-obesity drugs, including Ozempic, Wegovy and Mounjaro, have created buzz in the Indian markets. But are they really approved for use in India? What are their side-effects? And how much do ...

Powerful new medications such as Ozempic and Mounjaro, known as GLP-1 drugs are helping to win the war against obesity in ...

Some patients reluctantly shifted to save money while others have appealed for coverage of Zepbound after having experienced ...

These healthcare leaders still could perform well in the long run. Novo Nordisk has been facing several challenges that ...

This article delves into the approved weight loss drugs in India, their costs, and the growing market for such medications.